SCNX today
$3.04+$0.00 (+0.00%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minBearish
5 minConsolidating
Daily trend turns up above $4.26
Key levels
Resistance$4.26
Resistance$3.47
Support$2.64
Latest news & SEC filings
AnalystMaxim Group keeps Buy rating on Scienture Holdings, cuts price target
AnalystMaxim Group kept its Buy rating on Scienture (SCNX).
All SCNX news →About Scienture
Scienture is a specialty pharmaceutical company that develops and commercializes treatments for cardiovascular and central nervous system conditions. Its marketed products include Arbli, an oral liquid losartan formulation for hypertension, and Rezenopy, a naloxone nasal spray for opioid overdose. The company's development pipeline targets migraine, thrombosis, and pain, and it operates in the United States.
Based on the company's 10-K filed Mar 30, 2026.
Nasdaq · Healthcare
Scienture Holdings, Inc. (SCNX)
What Is the Price Target for SCNX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is SCNX a Buy or Sell Right Now?
Thesis
- •Revenue growing 215.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SCNX.
Start Free Trial →Is SCNX Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$4.20
47
Moat Score
NARROW
5/9
Piotroski Score
-0.5
Altman Z-Score
What Is Smart Money Doing with SCNX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SCNX Growth Story
Revenue YoY
215.9%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-208.87%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for SCNX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SCNX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:46:58 | $3.15 | 1,560 | $$5K | BUY |
| 20:33:11 | $3.21 | 1,000 | $$3K | SELL |
| 19:48:06 | $3.17 | 1,200 | $$4K | SELL |
| 16:55:50 | $3.15 | 2,800 | $$9K | SELL |
| 16:55:50 | $3.15 | 2,200 | $$7K | SELL |
5 dark pool trades shown · $$28K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Scienture Holdings, Inc. (SCNX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SCNX — frequently asked questions
What is SCNX stock price today?
Scienture Holdings, Inc. (SCNX) is at $3.04, up 0.00% (+$0.00) at the Nov 11, 2026 close.
Why is SCNX stock moving today?
Latest SCNX news — Oct 24, 2026: Maxim Group keeps Buy rating on Scienture Holdings, cuts price target · Oct 23, 2026: Maxim Group kept its Buy rating on Scienture (SCNX).
Did SCNX beat earnings?
SCNX last reported on Aug 14, 2026: EPS -$0.07 vs -$0.08 expected — a beat of 12.5%.
Does SCNX pay a dividend?
Yes. SCNX's dividend yield is 72.76%.
What are SCNX support and resistance levels?
Support: $2.64. Resistance: $3.47, $4.26, $8.82.
What are insiders doing with SCNX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on SCNX?
Oct 24, 2026: Maxim Group keeps Buy rating on Scienture Holdings, cuts price target · Oct 23, 2026: Maxim Group kept its Buy rating on Scienture (SCNX).